| 000 | 01917 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515065858.0 | ||
| 264 | 0 | _c20071102 | |
| 008 | 200711s 0 0 eng d | ||
| 022 | _a1556-6811 | ||
| 024 | 7 |
_a10.1128/CVI.00039-07 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWedege, E | |
| 245 | 0 | 0 |
_aFunctional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines. _h[electronic resource] |
| 260 |
_bClinical and vaccine immunology : CVI _cJul 2007 |
||
| 300 |
_a830-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
| 650 | 0 | 4 |
_aAntigens, Bacterial _ximmunology |
| 650 | 0 | 4 | _aBacterial Capsules |
| 650 | 0 | 4 |
_aBacterial Outer Membrane Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoblotting |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 |
_aLipopolysaccharides _xadministration & dosage |
| 650 | 0 | 4 |
_aMeningococcal Infections _ximmunology |
| 650 | 0 | 4 |
_aMeningococcal Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeisseria meningitidis, Serogroup B _ximmunology |
| 650 | 0 | 4 | _aNew Zealand |
| 650 | 0 | 4 |
_aPhagocytosis _ximmunology |
| 650 | 0 | 4 |
_aPolysaccharides, Bacterial _xadministration & dosage |
| 700 | 1 | _aBolstad, K | |
| 700 | 1 | _aAase, A | |
| 700 | 1 | _aHerstad, T K | |
| 700 | 1 | _aMcCallum, L | |
| 700 | 1 | _aRosenqvist, E | |
| 700 | 1 | _aOster, P | |
| 700 | 1 | _aMartin, D | |
| 773 | 0 |
_tClinical and vaccine immunology : CVI _gvol. 14 _gno. 7 _gp. 830-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/CVI.00039-07 _zAvailable from publisher's website |
| 999 |
_c17039947 _d17039947 |
||